PERSPECTA

News from every angle

← Back to headlines

Eli Lilly (LLY) Releases Positive Results From Phase 3 VIVID-2 Open-Label Extension Study

25 Feb, 16:10 — 25 Feb, 16:10
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

Yahoo1h ago

Eli Lilly (LLY) Releases Positive Results From Phase 3 VIVID-2 Open-Label Extension Study

Read full article →

Related Stories

ICPC warns Borno health officials against drug diversion and bribery

just now

22-year-old from Pyrgos Hospitalized with Meningitis

11m ago

Health advocates call for nationwide HPV Vaccination for boys

12m ago

Pilot Project for Continuous Care Extended in Portugal

14m ago